Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lung Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01456741
What this trial is testing

The Role of Endobronchial Needle Aspiration With Rapid On-site Evaluation in the Diagnosis of Central Malignant Lesions

Who this might be right for
Lung Cancer
University of Milan 134
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT06937112
What this trial is testing

18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

Who this might be right for
Lung CancersPancreatic CancerNeuroendocrine Tumors+1 more
Nanjing First Hospital, Nanjing Medical University 20
Not applicableLooking for participantsNCT05857995
What this trial is testing

Precision Lung Cancer Survivorship Care Intervention

Who this might be right for
Lung CancerPulmonary NeoplasmNeoplasms, Lung+12 more
Jerod L Stapleton, PhD 300
Testing effectiveness (Phase 2)Study completedNCT00509041
What this trial is testing

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599
What this trial is testing

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Who this might be right for
Malignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more
Genmab 350
Testing effectiveness (Phase 2)Study completedNCT00006014
What this trial is testing

SU5416 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Ended earlyNCT04370834
What this trial is testing

Tocilizumab for Patients With Cancer and COVID-19 Disease

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmPneumonia+3 more
National Cancer Institute (NCI) 1
Early research (Phase 1)Not Yet RecruitingNCT07110363
What this trial is testing

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

Who this might be right for
Advanced Malignant Solid TumorAdvanced Lung CancerNon-Small Cell Lung Cancer+1 more
Biotroy Therapeutics 58
Not applicableStudy completedNCT02575898
What this trial is testing

Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study

Who this might be right for
Primary Malignant Neoplasm of LungPrimary Malignant Neoplasm of Gastrointestinal Tract
Dartmouth-Hitchcock Medical Center 23
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Testing effectiveness (Phase 2)UnknownNCT04026841
What this trial is testing

The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density.

Who this might be right for
Multiple Primary Lung Cancers
The First Affiliated Hospital of Guangzhou Medical University 36
Early research (Phase 1)WithdrawnNCT02661659
What this trial is testing

A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
University of Chicago
Testing effectiveness (Phase 2)Ended earlyNCT03175172
What this trial is testing

Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 10
Not applicableStudy completedNCT01730365
What this trial is testing

Optical Detection of Malignancy During Percutaneous Interventions

Who this might be right for
Pulmonary Coin LesionColon Cancer Liver MetastasisBreast Cancer
Philips Healthcare 104
Testing effectiveness (Phase 2)UnknownNCT01649024
What this trial is testing

A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese 29
Testing effectiveness (Phase 2)UnknownNCT01871454
What this trial is testing

Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers

Who this might be right for
Non-small Cell Lung Cancers
University of Louisville 59
Not applicableLooking for participantsNCT07487883
What this trial is testing

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Who this might be right for
Non-Small Cell Lung CancerMalignant NeoplasmPulmonary Nodules+1 more
Peking University People's Hospital 80
Not applicableUnknownNCT02805062
What this trial is testing

Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy

Who this might be right for
Pleural Effusion, Malignant
NHS Greater Glasgow and Clyde 65
Early research (Phase 1)Study completedNCT00402766
What this trial is testing

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

Who this might be right for
Mesothelioma
M.D. Anderson Cancer Center 19
Next Page